BIOL (BIOLASE Inc.) Return on Sales by Gross Profit

BIOL (Biolase Inc.) - company brandmark

BIOLASE, Inc. (BIOL) is a recognized global benchmark in the dental laser segment with high physician loyalty. Analyzing the gross income metric in GURU.Markets, we note that 34.30 reflects the level of this metric. Waterlase technology makes treatment painless, attracting premium clinics; however, market conservatism and the risk of delisting due to losses force the company to conduct secondary offerings.

BIOLASE, Inc. (BIOL): Gross Margin from 07/04/2022 to 08/04/2024

Comprehensive metric breakdowns and analytics for BIOLASE, Inc. (BIOL)

- stock quotes and analyst forecast:
- business market valuation indicators:
Fundamental valuation:BIOL BIOLASE Inc.
Finished products of Biolase Inc.

Fundamental risks for BIOLASE, Inc. (BIOL) are determined by the company's ability to maintain high profitability during the precision assembly of dental lasers and compliance with RoHS environmental directives. Gross margin measures the portion of revenue remaining after covering direct production costs, allowing for an assessment of cost management efficiency. Analyzing the company's gross profit margin helps investors identify deviations from market standards and forecast the sustainability of bottom-line profit.

Main competitors

BSX - Return on Sales by Gross Profit|EW (Edwards) - Gross Margin|Return on Gross Profit ResMed Corp (RMD)|Gross Margin PODD|Gross Margin zimmerbiomet.com (ZBH)|Gross Profitability CooperCompanies COO|Gross Margin Invisalign ALGN|GMED - Gross Profitability|TMDX: Gross Profitability|ATEC (Alphatec Holdings, Inc.) - Return on Gross Profit|Artivion, Inc. - Gross Profit Rate|ENOV (Enovis Inc.) - Gross Margin|Gross Profit Margin Integra LifeSciences Corp IART|Gross Profitability Establishment Labs Corp (ESTA)|Beta Bionics Inc (BBNX) - Gross Sales Margin|IRADIMED Inc. - Return on Gross Profit|Gross Margin Embecta Corp. EMBC|Tandem Diabetes Care Inc - Gross Margin|Return on Sales by Gross Profit AxoGen Inc AXGN|SI-BONE (SIBN) - Gross Profitability|Gross Profitability Margin OFIX (Orthofix Corp)|BVS (Bioventus Inc) - Gross Margin|Return on Gross Profit OrthoPediatrics Corp. (KIDS)|Gross Margin TMCI|SRTA - Gross Profit Margin|Gross Profitability Carlsmed Inc CARL|RXST: Gross Return on Sales|CLPT: Return on Gross Profit|stereotaxis.com - Gross Profit Ratio|NeuroStar (STIM) - Gross Profitability|SGHT - Return on Sales by Gross Profit|Gross Profitability Orchestra BioMed|Gross Return on Sales ANIK (Anika Therapeutics)|Gross Profitability inspiremd.com (NSPR)|Jin Medical International Ltd - Gross Return on Sales|Gross Margin VANI (Vivani Medical Inc)|XTNT: Gross Return on Sales|NMTC - Gross Profitability|MODD: Gross Profitability|MYO: Gross Margin|envoymedical.com - Gross Profit Rate|Return on Gross Profit VVOS|Gross Profit Margin enVVeno NVNO|Gross Margin SINT|TNON - Gross Profit Margin|Gross Profitability ReWalk Robotics LFWD|AMIX: Gross Return on Sales|IVF - Gross Profitability|Gross Profit Margin Bone Biologics Corp|AXNX: Gross Margin|DYNT - Return on Sales by Gross Profit|FNA (paragon28.com) - Gross Margin|Gross Profit Margin invobioscience.com INVO